Inside Deal: Norman Hames Unloaded 2,500 Shares of RadNet Inc. (NASDAQ:RDNT)

November 29, 2016 - By Winifred Garcia

Inside Deal: Norman Hames Unloaded 2,500 Shares of RadNet Inc. (NASDAQ:RDNT)

Norman Hames Insider Sell

Norman Hames; that is an insider in Radnet Inc who is the latest to sell shares in the company for which he is for the time being a Executive Vice President. He in the last few days unloaded 2,500 shares of the company, with a total value $15,515 US Dollars, that is a price per share of nearly $6.2. He also sold 7,322 shares worth total $44,799 USD in the last month. Norman Hames right now possess 1.33% of Radnet Inc’s stock market capitalization with ownership of 621,050 shares.  Dated 29/11/2016 the transaction document is on hand here.

RadNet Inc. (NASDAQ:RDNT) Ratings Coverage

Out of 3 analysts covering RadNet (NASDAQ:RDNT), 1 rate it a “Buy”, 0 “Sell”, while 2 “Hold”. This means 33% are positive. $9 is the highest target while $8 is the lowest. The $8.50 average target is 37.10% above today’s ($6.2) stock price. RadNet has been the topic of 3 analyst reports since March 15, 2016 according to StockzIntelligence Inc. As per Tuesday, March 15, the company rating was maintained by Jefferies. The firm has “Buy” rating given on Friday, April 15 by Sidoti. The stock of RadNet Inc. (NASDAQ:RDNT) has “Neutral” rating given on Thursday, June 2 by Sterne Agee CRT.

Insitutional Activity: The institutional sentiment decreased to 1.08 in 2016 Q2. Its down 0.47, from 1.55 in 2016Q1. The ratio dropped, as 10 funds sold all RadNet Inc. shares owned while 23 reduced positions. 13 funds bought stakes while 38 increased positions. They now own 21.64 million shares or 1.94% more from 21.22 million shares in 2016Q1.

Miracle Mile Advsrs Ltd Liability Corp has invested 0.17% of its portfolio in RadNet Inc. (NASDAQ:RDNT). Tfs Limited Liability Company holds 0.24% of its portfolio in RadNet Inc. (NASDAQ:RDNT) for 244,136 shares. Geode Mgmt Limited Liability Corporation has 236,718 shares for 0% of their US portfolio. Aqr Mgmt Ltd Llc accumulated 0% or 51,322 shares. Schwab Charles Mgmt Inc holds 0% or 442,471 shares in its portfolio. Strs Ohio holds 0% or 116,900 shares in its portfolio. Eqis Capital Mngmt holds 0.46% of its portfolio in RadNet Inc. (NASDAQ:RDNT) for 1.27M shares. State Common Retirement Fund has invested 0% of its portfolio in RadNet Inc. (NASDAQ:RDNT). American International last reported 0% of its portfolio in the stock. Excalibur Corp holds 0.05% or 10,000 shares in its portfolio. Moreover, Voya Investment Mngmt has 0% invested in RadNet Inc. (NASDAQ:RDNT) for 18,180 shares. Oxford Asset Mgmt holds 164,170 shares or 0.04% of its portfolio. Savings Bank Of Mellon last reported 0% of its portfolio in the stock. Blackrock Fund Advsr owns 962,698 shares or 0% of their US portfolio. Blackrock Advsr Limited Liability Com, a Delaware-based fund reported 18,537 shares.

Insider Transactions: Since August 12, 2016, the stock had 0 insider buys, and 4 selling transactions for $602,037 net activity. Shares for $143,600 were sold by Forthuber Stephen M. The insider LINDEN JEFFREY L sold $192,300. The insider STOLPER MARK sold 35,414 shares worth $221,338. Shares for $44,799 were sold by HAMES NORMAN R.

About 43,080 shares traded hands. RadNet Inc. (NASDAQ:RDNT) has risen 11.93% since April 26, 2016 and is uptrending. It has outperformed by 6.67% the S&P500.

RadNet, Inc. is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. The company has a market cap of $283.45 million. The Firm operates directly or indirectly through joint ventures with hospitals, approximately 300 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island. It has a 65.4 P/E ratio. The Company’s centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders.

According to Zacks Investment Research, “RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.”

Analysts await RadNet Inc. (NASDAQ:RDNT) to report earnings on March, 13. They expect $0.11 earnings per share, up 57.14% or $0.04 from last year’s $0.07 per share. RDNT’s profit will be $5.03 million for 14.09 P/E if the $0.11 EPS becomes a reality. After $0.04 actual earnings per share reported by RadNet Inc. for the previous quarter, Wall Street now forecasts 175.00% EPS growth.

More recent RadNet Inc. (NASDAQ:RDNT) news were published by: Marketwatch.com which released: “/quotes/zigman/3870025/realtime” on November 16, 2010. Also Prnewswire.com published the news titled: “RadNet, Inc., a national leader in outpatient diagnostic imaging, selects ..” on July 26, 2016. Streetinsider.com‘s news article titled: “Form 4 RadNet, Inc. For: Nov 28 Filed by: HAMES NORMAN R” with publication date: November 29, 2016 was also an interesting one.

RDNT Company Profile

RadNet, Inc., incorporated on June 19, 2008, is a well-known provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. The Firm operates directly or indirectly through joint ventures with hospitals, approximately 300 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island. The Company’s centers provide physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. The Company’s services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures. The Firm operates approximately 140 fixed-site, freestanding outpatient diagnostic imaging facilities in California, over 10 in Delaware, three in Florida, 50 in Maryland, 20 in New Jersey, 20 in the Rochester and Hudson Valley areas of New York, approximately 40 in New York City, as well as five in Rhode Island.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Tags: , ,

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>